Figure 1. Effect of silymarin on body weight in different animal groups at the end of the experimental period. *P < 0.05 with respect to control group. #P < 0.05 with respect to diabetic group


Silymarin ameliorates Metabolic Risk Factors and Protects against Cardiac Apoptosis in Streptozotocin-induced Diabetic Rats

Monera A Alabdan

Biomedicine and Biotechnology. 2015, 3(2), 20-27 doi:10.12691/bb-3-2-1